Venous thromboembolism (VTE), which encompasses deep vein thrombosis (DVT) and
pulmonary embolism (PE), is a significant cause of morbidity and mortality worldwide. There …

Factor V Leiden thrombophilia is characterized by a poor anticoagulant response to
activated protein C (APC) and an increased risk for venous thromboembolism (VTE). Deep …

Decision analysis can play an essential role in informing practice guidelines. The American
Society of Hematology (ASH) thrombophilia guidelines have made a significant step forward …

Splanchnic vein thrombosis (SVT), a thrombosis which involves the portal, mesenteric, and
splenic veins, and the Budd-Chiari syndrome, represents an uncommon type of venous …

Introduction Thrombophilia testing (TT) is a laboratory procedure designed to detect the risk
factors involved in the pathogenesis of vascular occlusions. The role of TT is also …

Simple Summary Cancer patients are at greater risk of developing venous
thromboembolism compared to the general population, which can lead to a decreased …

Venous thromboembolism (VTE) is frequently encountered across various specialties. The
management of VTE has become more nuanced, requiring consideration of several factors …

VTE remains a significant health care challenge, demanding vigilance, knowledge, and a
multidisciplinary approach. Treatment and prophylaxis recommendations are based on …

Current hospital venous thromboembolism (VTE) prophylaxis for medical patients is
characterized by both underuse and overuse. The American Society of Hematology (ASH) …

Thrombophilia Management Calculator Page 1 American Society of Hematology 2021 L
Street NW, Suite 900, Washington, DC 20036 Phone: 202-776-0544 | Fax 202-776-0545 …